Influence of dietary resveratrol on early and late molecular markers of 1,2-dimethylhydrazine-induced colon carcinogenesis

Nutrition

Volumn 25, Issue 11-12, 2009, Pages 1169-1176

  Sengottuvelan, Murugan ^a   Deeptha, Kumaraswamy ^a   Nalini, Namasivayam ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

1,2 Dimethylhydrazine; Apoptosis; Cell proliferation; Chemoprevention; Resveratrol

Indexed keywords

1,2 DIMETHYLHYDRAZINE; CASPASE 3; CYCLOOXYGENASE 2; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; MOLECULAR MARKER; MUCIN 1; MUCIN 2; ORNITHINE DECARBOXYLASE; RESVERATROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER PREVENTION; CELL PROLIFERATION; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; DIET; DRUG MECHANISM; EXTRACTION; IMMUNOBLOTTING; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SUPPLEMENTATION;

1,2-DIMETHYLHYDRAZINE; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BIOLOGICAL MARKERS; CELL PROLIFERATION; COLON; COLONIC NEOPLASMS; DIET; DISEASE MODELS, ANIMAL; INFLAMMATION; INTESTINAL MUCOSA; MALE; MUCIN-1; MUCIN-2; PLANT EXTRACTS; RANDOM ALLOCATION; RATS; RATS, WISTAR; STILBENES;

RATTUS;

EID: 70349775853     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2009.03.009     Document Type: Article

References (45)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., et al. Cancer statistics, 2008. CA Cancer J Clin 58 (2008) 71-96
2. Franco A., Sikalidis A.K., and Solis Herruzo J.A. Colorectal cancer: influence of diet and lifestyle factors. Rev Esp Enferm Dig 97 (2005) 32-48
3. Bruce W.R., Archer M.C., Corpet D.E., Medline A., Minkin S., Stamp D., et al. Diet, aberrant crypt foci and colorectal cancer. Mutat Res 290 (1993) 111-118
4. Reddy B.S., Narisawa T., Wright P., Vukusich D., Weisburger J.H., and Wynder E.L. Colon carcinogenesis with azoxymethane and dimethylhydrazine in germ-free rats. Cancer Res 35 (1975) 287-290
5. Smith W.L., and Langenbach R. Why there are two cyclooxygenase isoenzymes. J Clin Invest 107 (2001) 1491-1495
6. Prescott S.M., and White R.L. Self-promotion? Intimate connections between APC and prostaglandin H synthase-2. Cell 87 (1996) 783-786
7. Erickson B.A., Longo W.E., Panesar N., Mazuski J.E., and Kaminski D.L. The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis. J Surg Res 81 (1999) 101-107
8. Ostrowski J., Wocial T., Skurzak H., and Bartnik W. Do altering in ornithine decarboxylase activity and gene expression contribute to antiproliferative properties of COX inhibitors?. Br J Cancer 88 (2003) 1143-1151
9. Gerner E.W., and Meyskens Jr. F.L. Polyamines and cancer: old molecules, new understanding. Nat Rev Cancer 4 (2004) 781-792
10. Creagh E.M., and Martin S.J. Caspases: cellular demolition experts. Biochem Soc Trans 29 (2001) 696-702
11. Garrido C., Fromentin A., Bonnotte B., Favre N., Moutet M., Arrigo A.P., et al. Heat shock protein 27 enhances the tumorigenicity of immunogenic rat colon carcinoma cell clones. Cancer Res 58 (1998) 5495-5499
12. Carraway K.L., Ramsauer V.P., Haq B., and Carothers Carraway C.A. Cell signaling through membrane mucins. Bioessays 25 (2003) 66-71
13. Hollingsworth M.A., and Swanson B.J. Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer 4 (2004) 45-60
14. Morse M.A., and Stoner G.D. Cancer chemoprevention: principles and prospects. Carcinogenesis 14 (1993) 1737-1746
15. Paul B., Masih I., Deopujari J., and Charpentier C. Occurrence of resveratrol and pterostilbene in age-old darakchasava, an Ayurvedic medicine from India. J Ethnopharmacol 68 (1999) 71-76
16. Bhat K.P., Lantvit D., Christov K., Mehta R.G., Moon R.C., and Pezzuto J.M. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. Cancer Res 61 (2001) 7456-7463
17. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275 (1997) 218-220
18. Sengottuvelan M., Senthilkumar R., and Nalini N. Modulatory influence of dietary resveratrol during different phases of 1,2-dimethylhydrazine induced mucosal lipid-peroxidation, antioxidant status and aberrant crypt foci development in rat colon carcinogenesis. Biochim Biophys Acta 1760 (2006) 1175-1183
19. Sengottuvelan M., Viswanathan P., and Nalini N. Chemopreventive effect of trans-resveratrol-a phytoalexin against colonic aberrant crypt foci and cell proliferation in 1,2-dimethylhydrazine induced colon carcinogenesis. Carcinogenesis 27 (2006) 1038-1046
20. Bradford M.M. A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
21. Laemmeli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
22. Towbin H., Staehelin T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 76 (1979) 4350-4354
23. Shukitt-Hale B., Kalt W., Carey A.N., Vinqvist-Tymchuk M., McDonald J., and Joseph J.A. Plum juice, but not dried plum powder, is effective in mitigating cognitive deficits in aged rats. Nutrition 25 (2009) 567-573
24. Tuynman J.B., Peppelenbosch M.P., and Richel D.J. COX-2 inhibition as a tool to treat and prevent colorectal cancer. Crit Rev Oncol Hematol 52 (2004) 81-101
25. Suh N., Paul S., Hao X., Simi B., Xiao H., Rimando A.M., et al. Pterostilbene, an active constituent of blueberries, suppresses aberrant crypt foci formation in the azoxymethane-induced colon carcinogenesis model in rats. Clin Cancer Res 13 (2007) 350-355
26. Russell D.H. Ornithine decarboxylase: a key regulatory enzyme in normal and neoplastic growth. Drug Metab Rev 16 (1985) 1-88
27. Wolter F., Akoglu B., Clausnitzer A., and Stein J. Downregulation of the cyclin D1/Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines. J Nutr 131 (2001) 2197-2203
28. Suzuki R., Kuroda H., Komatsu H., Hosokawa Y., Kagami Y., Ogura M., et al. Selective usage of D-type cyclins in lymphoid malignancies. Leukemia 13 (1999) 1335-1342
29. Carlson B., Lahusen T., Singh S., Loaiza-Perez A., Worland P.J., Pestell R., et al. Down-regulation of cyclin D1 by transcriptional repression in MCF-7 human breast carcinoma cells induced by flavopiridol. Cancer Res 59 (1999) 4634-4641
30. Hsieh T.C., and Wu J.M. Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines. Exp Cell Res 249 (1999) 109-115
31. Choubey D., and Gutterman J.U. Inhibition of E2F-4/DP-1-stimulated transcription by p202. Oncogene 15 (1997) 291-301
32. Fontecave M., Lepoivre M., Elleingand E., Gerez C., and Guittet O. Resveratrol, a remarkable inhibitor of ribonucleotide reductase. FEBS Lett 42 (1998) 277-279
33. Bedi A., Pasricha P.J., Akhtar A.J., Barber J.P., Bedi G.C., Giardiello F.M., et al. Inhibition of apoptosis during development of colorectal cancer. Cancer Res 55 (1995) 1811-1816
34. Kerr J.F., Wyllie A.H., and Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26 (1972) 239-257
35. Juan M.E., Wenzel U., Daniel H., and Planas J.M. Resveratrol induces apoptosis through ROS-dependent mitochondria pathway in HT-29 human colorectal carcinoma cells. J Agric Food Chem 56 (2008) 4813-4818
36. Hwang J.T., Kwak D.W., Lin S.K., Kim H.M., Kim Y.M., and Park O.J. Resveratrol induces apoptosis in chemoresistant cancer cells via modulation of AMPK signaling pathway. Ann N Y Acad Sci 1095 (2007) 441-448
37. Park J.W., Woo K.J., Lee J.T., Lim J.H., Lee T.J., Kim S.H., et al. Resveratrol induces pro-apoptotic endoplasmic reticulum stress in human colon cancer cells. Oncol Rep 18 (2007) 1269-1273
38. Trincheri N.F., Nicotra G., Follo C., Castino R., and Isidoro C. Resveratrol induces cell death in colorectal cancer cells by a novel pathway involving lysosomal cathepsin D. Carcinogenesis 28 (2007) 922-931
39. Mohan J., Gandhi A.A., Bhavya B.C., Rashmi R., Karunagaran D., Indu R., et al. Caspase-2 triggers Bax-Bak-dependent and -independent cell death in colon cancer cells treated with resveratrol. J Biol Chem 281 (2006) 17599-17611
40. Nalini N., Sabitha K., Chitra S., Viswanathan P., and Menon V.P. Histopathological and lipids changes in experimental colon cancer: effect of coconut kernel (Cocos nucifera Linn.) and (Capsicum annum Linn.) red chilli powder. Indian J Exp Biol 35 (1997) 964-971
41. Morimoto R.I. Heat shock: the role of transient inducible responses in cell damage, transformation, and differentiation. Cancer Cell 3 (1991) 295-301
42. Samali A., and Cotter T.G. Heat shock proteins increase resistance to apoptosis. Exp Cell Res 223 (1996) 163-170
43. Kohler G., Veelken H., Rosenthal F., Mackensen A., Lindemann A., Schaefer H.E., et al. Oncogene and HSP-70 expression in primary tumor cell cultures of renal cell carcinoma compared to their corresponding cell line. Anticancer Res 17 (1997) 3225-3231
44. Van der Sluis M., De Koning B.A., De Bruijn A.C., Velcich A., Meijerink J.P., Van Goudoever J.B., et al. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 131 (2006) 117-129
45. Apostolopoulos V., Xing P.X., and McKenzie I.F. Murine immune response to cells transfected with human MUC1: immunization with cellular and synthetic antigens. Cancer Res 54 (1994) 5186-5193